Accumulating evidence indicates that Wnt co-receptor LRP6 play a critical role in the Wnt/β-catenin signaling activation in human prostate and breast cancer cells and is important in the development and progression of these two types of cancer [8], [13], [14], [29]–[33]. Here, LRP6 is linked to breast carcinoma.